President Tsai registers for Medigen COVID vaccine (2021/07/28)
其它新聞 Other News   
  • Olympics roundup: Lin Yun-ju advances to table tennis semis, Tai Tzu-ying enters quarters
  • In profile: Kuo Hsing-chun conquers adversity to lift Olympic gold
  • Vaccination rate nears 30%, registration opens for second dose of Moderna
  • Junior high school students make searchable COVID vaccine center map
  • Academia Sinica raises Taiwan’s GDP growth forecast to 5.05% in 2021
  • University entrance exams kick off with strict public health guidelines
  • Power use soars to 38,844 megawatts on first day of Level 2
  • Police processing up to 200 criminal record checks a day as people switch jobs
  • Lithuania showered with love from Taiwan after COVID vaccine donation
  • 英文 English 
    President Tsai registers for Medigen COVID vaccine (2021/07/28)

    President Tsai Ing-wen has signed up for the waitlist of Taiwan's Medigen COVID vaccine. The president made the announcement Wednesday on social media.
    She wrote that her administration would only provide the public with "safe, effective, and legal" vaccines that met scientific standards. She said she herself would be taking the Medigen vaccine.

    Tsai Ing-wen
    The vaccination rate has already surpassed our target of 25% by July 31, and we have added our domestic vaccine to our list of offered brands. Yesterday I completed the process of vaccine registration. I selected the domestic vaccine on the preference list.

    Not only that, the vice president may get a domestic vaccine, too. According to the Presidential Office spokesman, Vice President Lai Ching-te is leaning toward getting the vaccine developed by the Hsinchu-based United Biomedical, which is still under review for emergency use authorization.
    中文 Chinese  
    蔡英文完成預約高端疫苗 賴清德傾向接種聯亞疫苗


    [[總統 蔡英文]]

    關於民視 常見問題 如何收看民視 意見信箱

    © 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
    地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

    本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。